$Applied DNA Sciences (APDN.US)$ I've got my eyes on this and will likely be taking a position on Tuesday. Keep it on watch or consider a swing position.
3
4
Report
Lnova
:
is it due to this as a catalyst? seekingalpha.co...
$Inovio Pharmaceuticals (INO.US)$Benzinga· 4 mins ago INOVIO Announces Phase 1/2 Trial Results Of INO-3107 For Recurrent Respiratory Papillomatosis With 81% Of Patients Requiring Fewer Surgeries; Plans BLA Submission In Mid-2025 For FDA Accelerated Approval, Aiming To Achieve First US DNA Medicine Approval
I've got my eyes on this and will likely be taking a position on Tuesday. Keep it on watch or consider a swing position.
Breakthrough RRP Treatment Slashes Surgery Need: 28% of Patients Now Surgery-Free in Nature Communications Study
INOVIO Announces Phase 1/2 Trial Results Of INO-3107 For Recurrent Respiratory Papillomatosis With 81% Of Patients Requiring Fewer Surgeries; Plans BLA Submission In Mid-2025 For FDA Accelerated Approval, Aiming To Achieve First US DNA Medicine Approval
No comment yet